News

Extended Phase II study with Arnica against CL started in Colombia!

The extended clinical study investigating the efficacy of Arnica tincture against cutaneous Leishmaniasis has officially started at the University of Antioquia, Colombia: The first of 70 envisaged patients has enrolled today. The study now also comprises more complex cases (more than 2 lesions per patient, larger lesions, younger patients, lesions in more complex regions) and will also comprise a direct comparison with standard therapy, glucantime. ResNet NPND wishes all patients who participate in the study a successful treatment and quick and complete healing!